Annual General Meeting of Shareholders – Lavipharm S.A.:
Posted at h
in General Meetings and Corporate Actions
Paiania, 3 July 2025 – Lavipharm S.A. (LAVI) held its Annual General Meeting at the company’s headquarters in Paiania, with a quorum achieved, as 34 shareholders representing 70,34% of the share capital were present. CEO Tilemachos Lavidas opened the session by welcoming shareholders and announcing the departure of Mr. Minas Tanes as Chairman of the Board. He expressed appreciation for Mr. Tanes’ years of dedicated service and his vital role in the company’s growth. The new Chair of the Board is Ms. Sofia Kounenaki-Efraimoglou, the first woman to hold this position in Lavipharm’s history. 
